The foundation:
News

Video: ADAPTED Project

 

 

The ADAPTED project (Alzheimer’s Disease Apolipoprotein Pathology for Treatment Elucidation and Development), led by Fundació ACE, is a research study that investigates the biological mechanisms through which the presence of the APOE gene increases the risk of developing Alzheimer's. The ultimate goal is to determine new treatment and prevention strategies for this disease.

The APOE gene is a protein involved in the transport of cholesterol. Carrying the genetic variant known as APOE4 is one of the most important risk factors for developing Alzheimer's. Although this fact has been known for more than twenty years, the molecular mechanisms by which this happens are still unknown, since it has received less attention from the scientific community so far.

The ADAPTED project, that has a budget of 7 million euros, is funded by IMI (Innovative Medicines Initiative) a public-private consortium between the EU and the European Federation of Pharmaceutical Industries and Associations (EFPIA), created to boost pharmaceutical innovation in Europe and accelerate the development of more effective and safe medicines.

 

 

You might also like

Fundació ACE takes part in the 3rd Sino-German symposium on preclinical Alzheimer's

04/11/2019Research
Agustín Ruiz, head of research at Fundació ACE presented this weekend the GRA@CE study on the 3rd Sino-German Symposium on preclinical Alzheimer's that was held on November 1st - 4th at Nanjing University (China).